Andrea Loreto
6PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 12, 2025
Programmed axon degeneration: mechanism, inhibition and therapeutic potential.Andrea Loreto, Lukas J Neukomm
|Sep 17, 2024
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production.James R Tribble, Melissa Jöe, Carmine Varricchio
|Jul 24, 2024
NMNAT2 is a druggable target to drive neuronal NAD production.James R Tribble, Melissa Jöe, Carmine Varricchio
|Mar 28, 2024
Programmed axon death: a promising target for treating retinal and optic nerve disorders.Andrea Loreto, Elisa Merlini, Michael P Coleman
|Dec 08, 2022
The NAD+ precursor NMN activates dSarm to trigger axon degeneration in Drosophila.Arnau Llobet Rosell, Maria Paglione, Jonathan Gilley
|Dec 06, 2021
Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1.Andrea Loreto, Carlo Angeletti, Weixi Gu
Pageof 1
Frequent Collaborators
2 joint publications
Alessio Canovai
2 joint publications
Craig E Wheelock
2 joint publications
Jonathan Gilley
2 joint publications
Baninia Habchi
2 joint publications
Pete A Williams
2 joint publications
Melissa Jöe
2 joint publications
Giuseppe Orsomando
2 joint publications
Raymond C B Wong
2 joint publications
Romanas Chaleckis
2 joint publications
James R Tribble
